Literature DB >> 2906640

Cyclin mRNA and protein expression in recombinant interleukin 2-stimulated cloned murine T lymphocytes.

P M Shipman1, D E Sabath, A H Fischer, P G Comber, K Sullivan, E M Tan, M B Prystowsky.   

Abstract

Expression of cyclin, a non-histone nuclear protein, during recombinant interleukin 2 (rIL2)-driven cell-cycle progression of cloned T lymphocytes has been assessed. We found that expression of cyclin protein, as detected by immunofluorescence, is tightly associated with proliferation, and not merely S-phase, of L2 cells stimulated with rIL2. Cyclin immunofluorescence was detected in all cell-cycle phases (G1/S/G2/M, as detected by flow cytometry) of proliferating L2 cells. Accumulation of cyclin mRNA levels was induced as early as 1 h after stimulation, was maximal at 25-49 h, and remained elevated throughout stimulation, as detected by Northern blot analysis. A cDNA-encoding murine cyclin was cloned from a cDNA library prepared from IL2-stimulated cloned T cells. The sequence of the 5' end of the murine cyclin cDNA was determined and found to be 88% and 82% similar to the sequences of cDNA clones encoding rat and human cyclin, respectively. The present studies demonstrate that cyclin protein and mRNA accumulation are highly regulated during IL2-induced proliferation of a cloned T cell. These data provide a framework for addressing the molecular mechanisms regulating cyclin gene expression during cellular proliferation.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906640     DOI: 10.1002/jcb.240380306

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  The role of the promoter in the expression of the PCNA gene.

Authors:  R H Charollais; H Alder; A Ferber; J Koniecki; C Sell; R Baserga
Journal:  Gene Expr       Date:  1992

2.  Modulation of growth factor receptor function by isoform heterodimerization.

Authors:  W P Chang; C V Clevenger
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

3.  Induction of the autoantigen proliferating cell nuclear antigen in T lymphocytes by a mycobacterial antigen.

Authors:  H M Haftel; Y Chang; R Hinderer; S M Hanash; J Holoshitz
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

4.  Inhibition of T-cell proliferation by a MYB antisense oligomer is accompanied by selective down-regulation of DNA polymerase alpha expression.

Authors:  D Venturelli; S Travali; B Calabretta
Journal:  Proc Natl Acad Sci U S A       Date:  1990-08       Impact factor: 11.205

5.  Expression of proliferating cell nuclear antigen during the cell cycle of human diploid fibroblasts.

Authors:  C A Stewart; R T Dell'Orco
Journal:  In Vitro Cell Dev Biol       Date:  1992-03

6.  A conserved region in intron 1 negatively regulates the expression of the PCNA gene.

Authors:  H Alder; M Yoshinouchi; M B Prystowsky; P Appasamy; R Baserga
Journal:  Nucleic Acids Res       Date:  1992-04-11       Impact factor: 16.971

7.  Promoter activity of the proliferating-cell nuclear antigen gene is associated with inducible CRE-binding proteins in interleukin 2-stimulated T lymphocytes.

Authors:  D Huang; P M Shipman-Appasamy; D J Orten; S H Hinrichs; M B Prystowsky
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

8.  Transcriptional and posttranscriptional regulation of the proliferating cell nuclear antigen gene.

Authors:  C D Chang; L Ottavio; S Travali; K E Lipson; R Baserga
Journal:  Mol Cell Biol       Date:  1990-07       Impact factor: 4.272

9.  Importance of introns in the growth regulation of mRNA levels of the proliferating cell nuclear antigen gene.

Authors:  L Ottavio; C D Chang; M G Rizzo; S Travali; C Casadevall; R Baserga
Journal:  Mol Cell Biol       Date:  1990-01       Impact factor: 4.272

10.  Reciprocal role of cyclins and cyclin kinase inhibitor p21WAF1/CIP1 on lymphocyte proliferation, allo-immune activation and inflammation.

Authors:  Ashwani K Khanna
Journal:  BMC Immunol       Date:  2005-09-21       Impact factor: 3.615

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.